Testing of Bevacizumab, Erlotinib, and Atezolizumab for Advanced-Stage Kidney Cancer
Conditions:   Advanced Papillary Renal Cell Carcinoma;   Advanced Renal Cell Carcinoma;   Hereditary Leiomyomatosis and Renal Cell Carcinoma;   Stage III Renal Cell Cancer AJCC v8;   Stage IV Renal Cell Cancer AJCC v8 Interventions:   Biological: Atezolizumab;   Biological: Bevacizumab;   Drug: Erlotinib Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer
Conditions:   Stage I Prostate Cancer AJCC v8;   Stage II Prostate Cancer AJCC v8;   Stage IIA Prostate Cancer AJCC v8;   Stage IIB Prostate Cancer AJCC v8;   Stage IIC Prostate Cancer AJCC v8;   Stage III Prostate Cancer AJCC v8;   Stage IIIA Prostate Cancer AJCC v8;   Stage IIIB Prostate Cancer AJCC v8;   Stage IIIC Prostate Cancer AJCC v8 Interventions: &...
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplams
Conditions:   Cancer;   Myeloid Neoplasm Interventions:   Behavioral: GO-EXCAP Mobile App;   Behavioral: Behavioral Placebo Control Sponsors:   University of Rochester;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

A Study of AK104 Plus Platinum-containing Chemotherapy ±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
Condition:   Cervical Cancer Interventions:   Biological: AK104;   Drug: paclitaxel;   Drug: carboplatin;   Drug: cisplatin;   Drug: bevacizumab;   Drug: Placebo Sponsor:   Akeso Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer
Condition:   Advanced NSCLC Intervention:   Drug: REGN5093-M114 Sponsor:   Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Pulmonary Function After Arterial Sleeve Lobectomy
Condition:   Lung Cancer, Nonsmall Cell Intervention:   Procedure: Lobectomy with pulmonary artery reconstruction Sponsor:   Centre Hospitalier Régional Universitaire Montpellier Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Randomized Controlled Trial of Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer
Conditions:   Gastric Cancer;   Perioperative;   Sintilimab Interventions:   Drug: Sintilimab;   Drug: S-1;   Drug: Oxaliplatin Sponsor:   Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
Conditions:   Solid Tumor;   Glioblastoma;   Non-small Cell Lung Cancer;   Breast Cancer Intervention:   Drug: TAS2940 Sponsor:   Taiho Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Assessment of VMCore Biopsy Versus Standard of Care Biopsy
Condition:   Prostate Cancer Interventions:   Device: VMCore Biopsy System;   Device: Standard of Care Biopsy Needle Sponsor:   Uro-1 Medical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Anti-mesothelin CAR-T Cells With Advanced Refractory Solid Tumors
Condition:   Refractory Malignant Solid Neoplasm Intervention:   Biological: anti-MESO CAR T cells Sponsor:   Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
Conditions:   Liver and Intrahepatic Bile Duct Neoplasm;   Metastatic Malignant Neoplasm in the Liver;   Primary Malignant Liver Neoplasm Interventions:   Other: Quality-of-Life Assessment;   Procedure: Surgical Procedure Sponsor:   M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
Conditions:   Hepatocellular Carcinoma;   Adjuvant Therapy Interventions:   Drug: Tislelizumab;   Drug: TACE Sponsors:   Zhejiang University;   First Hospital of China Medical University;   Shandong Cancer Hospital and Institute;   The Affiliated Hospital Of Southwest Medical University;   Hainan People's Hospital;   Tianjin Third Central Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

PILOT: Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya
Condition:   HIV Prevention Intervention:   Behavioral: formal peer PrEP referral + HIVST delivery Sponsors:   Fred Hutchinson Cancer Research Center;   National Institute of Mental Health (NIMH) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
Condition:   Unresectable Stage III NSCLC Interventions:   Drug: Durvalumab;   Drug: Cisplatin/ Etoposide;   Drug: Carboplatin/ Paclitaxel;   Drug: Pemetrexed/ Cisplatin;   Drug: Pemetrexed/ Carboplatin;   Radiation: Radiation Sponsor:   Shandong Cancer Hospital and Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities
Condition:   Multiple Primary Lung Cancers Interventions:   Drug: furmonertinib;   Drug: Placebo Sponsors:   Ruijin Hospital;   Fujian Medical University Union Hospital;   First Affiliated Hospital of Zhejiang University;   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Tang-Du Hospital;   The First Affiliated Hospital of Nanchang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials

Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients
Condition:   ALK-positive Non-small-cell Lung Cancer Intervention:   Drug: Lorlatinib Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort
Condition:   Treatment of Deep Vein Thrombosis and/or Pulmonary Embolism in Cancer Patients Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Low molecular weight heparin (LMWH);   Drug: Direct Oral Anticoagulants (DOAC) Sponsor:   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

The Effect of Early Rehabilitation After Breast Cancer Surgery on Physical and Psychosocial Functions
Condition:   Breast Cancer Surgery Interventions:   Procedure: physitherapy follow-up;   Other: control Sponsor:   Pamukkale University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer
Condition:   Biliary Tract Carcinoma Intervention:   Combination Product: Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab Sponsor:   Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Emergency Department Lung Cancer URMFG Pilot
Condition:   Lung Cancer Intervention:   Behavioral: Text Messaging Sponsor:   University of Rochester Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

LaserEn: SOLTIVE ™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
Conditions:   Bladder Cancer;   Surgery Intervention:   Procedure: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors Sponsor:   University of Kansas Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
Conditions:   Hepatitis C Virus Infection;   Colorectal Cancer Intervention:   Behavioral: CARES-HCV Sponsor:   H. Lee Moffitt Cancer Center and Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

A Nutritional Intervention and Physical Activity Program Reduce Body Weight in Women Newly Diagnosed With Breast Cancer.
Conditions:   Breast Cancer;   Body Weight Changes;   Weight Loss;   Nutrition Related Cancer Interventions:   Behavioral: Control group;   Behavioral: Nutrition and physical activity group Sponsor:   Instituto de Investigación Hospital Universitario La Paz Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients
Conditions:   Non-small Cell Lung Cancer;   Cardiovascular Complication Intervention:   Drug: Multiple cardiovascular drugs related to " Golden Triangle " Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Promoting Radon Testing Via Smartphone App: A Clinical Trial in a High Radon State
Condition:   Lung Cancer Interventions:   Other: The radon app;   Other: Print brochure Sponsor:   University of North Dakota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors
Conditions:   Colorectal Cancer;   Colorectal Neoplasms;   Colorectal Carcinoma;   Colorectal Polyp;   Colorectal Adenoma Intervention:   Diagnostic Test: CELTiC test Sponsors:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Bergman Clinics;   University of Bologna Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Multi-dimensional Signatures for Precisely Predicting the Response and Prognosis of Lung Cancer Patients
Conditions:   Response;   Prognosis Intervention:   Other: real world treatment by doctors Sponsors:   Wuhan Union Hospital, China;   Renmin Hospital of Wuhan University;   Wuhan TongJi Hospital;   Wuhan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Mesogastrium Metastasis in Colon Cancer
Condition:   Colon Cancer Intervention:   Sponsor:   Jichao Qin Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Leukapheresis for CAR T- Cell Manufacturing
Conditions:   Solid Tumor, Adult;   Colorectal Cancer;   Non Small Cell Lung Cancer;   Pancreatic Cancer;   CRC;   NSCLC;   Pancreas Cancer Interventions:   Other: Leukapheresis;   Diagnostic Test: Next Generation Sequencing (NGS);   Diagnostic Test: Long Range NGS HLA typing Sponsors:   A2 Biotherapeutics Inc.;   Tempus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Follow-up of Early Breast Cancer (BC) Patients by Telephone or Mobile Software
Condition:   Breast Cancer, Early-Onset Intervention:   Device: Mobile software for follow-up of early breast cancer Sponsors:   Helsinki University Central Hospital;   University of Helsinki;   Noona Healthcare Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

" The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients "
Conditions:   Gastric Cancer;   Colorectal Cancer Intervention:   Dietary Supplement: Impact Oral Nestlé Health Science, Cubitan® Nutricia, Nutridrink® Nutricia, Resource 2.0 Nestlé Health Science Sponsor:   Medical University of Gdansk Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
Condition:   Prostate Cancer Intervention:   Device: ExactVu Sponsor:   Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors
Condition:   Advanced Malignant Tumors Intervention:   Biological: IBC0966 Sponsor:   SUNHO(China)BioPharmaceutical CO., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials

Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO) —efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up
DiscussionA better understanding of the efficiency and effects of opioid tapering could possibly facilitate attempts to taper opioid treatments, which might prove beneficial for both the individual and society.Trial registrationClinicalTrials.govNCT03485430. Retrospectively registered on 26 March 2018, first release date. “Tapering of Long-term Opioid Therapy in Chronic Pain Population. RCT with 12 Months Follow up (TOPIO).” First patient in trial 22 March 2018. (Source: Trials)
Source: Trials - July 28, 2021 Category: Research Source Type: clinical trials

GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors
Conditions:   Advanced Solid Tumor;   Metastatic Solid Tumor;   Non-small Cell Lung Cancer;   Head and Neck Squamous Cell Carcinoma;   Renal Cell Carcinoma;   Urinary Bladder Cancer;   Melanoma;   Sarcoma Interventions:   Drug: GI-101;   Drug: Pembrolizumab;   Drug: Lenvatinib;   Radiation: Local Radiotherapy Sponsors:   GI Innovation, Inc.;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer
Conditions:   Neuroendocrine Tumor of Pancreas;   Carcinoma, Pancreatic;   CT Intervention:   Other: No intervention Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Zhejiang University;   The First Affiliated Hospital of the Fourth Military Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer Intervention:   Drug: Anti-PD-1/PD-L1 monoclonal antibody Sponsor:   Shanghai Chest Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Abdominal Drainage vs Postoperative Antibiotico-prophylaxis vs Control in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis for Right Colon Cancer
Condition:   Colon Cancer Interventions:   Procedure: abdominal drainage;   Drug: Postoperative antibiotico-prophylaxis Sponsor:   University of Rome Tor Vergata Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy
Conditions:   Nasopharyngeal Carcinoma;   Nasopharyngeal Cancer Intervention:   Drug: Fluzoparib and Camrelizumab Sponsor:   Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Effectiveness of Cryotherapy Study for Prostate Cancer
Condition:   Prostate Cancer Intervention:   Procedure: Cryotherapy Sponsor:   Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer
Conditions:   Biochemically Recurrent Prostate Carcinoma;   Localized Prostate Carcinoma;   Prostate Adenocarcinoma Interventions:   Drug: Fluorine F 18 rhPSMA-7.3;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography Sponsor:   M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Progressive Relaxation Exercise on Dyspnea, Pain and Sleep Quality
Condition:   Cancer Intervention:   Behavioral: Progressive Relaxation Exercise Sponsor:   Istanbul Sabahattin Zaim University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer
Conditions:   Non-small Cell Lung Cancer;   Brain Metastases Intervention:   Drug: Anlotinib Sponsor:   Li-kun Chen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors
Conditions:   Sinonasal Carcinoma;   HPV-Related Squamous Cell Carcinoma Intervention:   Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Merck Sharp & Dohme Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Using Physical Tracking to Predict Sunburn
Condition:   Prevention Intervention:   Behavioral: Intervention Group Sponsors:   Klein Buendel, Inc.;   National Cancer Institute (NCI);   Colorado State University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study
Condition:   Lynch Syndrome Intervention:   Behavioral: Educational Workbook Sponsors:   UNC Lineberger Comprehensive Cancer Center;   National Center for Advancing Translational Science (NCATS);   University of North Carolina, Chapel Hill;   North Carolina Translational and Clinical Sciences Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
Condition:   Diffuse Large B-Cell Lymphoma Interventions:   Drug: Acalabrutinib;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Lenalidomide;   Drug: Prednisone;   Biological: Rituximab;   Biological: Tafasitamab;   Drug: Vincristine Sponsor:   M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors
Conditions:   Advanced Solid Tumor;   Metastatic Solid Tumor;   Non-small Cell Lung Cancer;   Head and Neck Squamous Cell Carcinoma;   Renal Cell Carcinoma;   Urinary Bladder Cancer;   Melanoma;   Sarcoma Interventions:   Drug: GI-101;   Drug: Pembrolizumab;   Drug: Lenvatinib;   Radiation: Local Radiotherapy Sponsors:   GI Innovation, Inc.;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer
Conditions:   Neuroendocrine Tumor of Pancreas;   Carcinoma, Pancreatic;   CT Intervention:   Other: No intervention Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Zhejiang University;   The First Affiliated Hospital of the Fourth Military Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials

HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors
Conditions:   Sinonasal Carcinoma;   HPV-Related Squamous Cell Carcinoma Intervention:   Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Merck Sharp & Dohme Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials